Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
A colorimetric method for the determination of glucosamine and chondrosamine
1.775
Zitationen
2
Autoren
1933
Jahr
Abstract
Research Article| January 01 1933 A colorimetric method for the determination of glucosamine and chondrosamine Leslie Alderman Elson; Leslie Alderman Elson 1 1The Serum Department, The Lister Institute, Elstree, Herts Search for other works by this author on: This Site PubMed Google Scholar Walter Thomas James Morgan Walter Thomas James Morgan 1The Serum Department, The Lister Institute, Elstree, Herts Search for other works by this author on: This Site PubMed Google Scholar Biochem J (1933) 27 (6): 1824–1828. https://doi.org/10.1042/bj0271824 Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn MailTo Cite Icon Cite Get Permissions Citation Leslie Alderman Elson, Walter Thomas James Morgan; A colorimetric method for the determination of glucosamine and chondrosamine. Biochem J 1 January 1933; 27 (6): 1824–1828. doi: https://doi.org/10.1042/bj0271824 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsBiochemical Journal Search Advanced Search This content is only available as a PDF. © 1933 CAMBRIDGE UNIVERSITY PRESS1933 Article PDF first page preview Close Modal You do not currently have access to this content.
Ähnliche Arbeiten
European Position Paper on Rhinosinusitis and Nasal Polyps 2020
2020 · 5.400 Zit.
EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists
2012 · 2.394 Zit.
Psychometric validity of the 22‐item Sinonasal Outcome Test
2009 · 1.537 Zit.
Staging in rhinosinusitus.
1993 · 1.518 Zit.
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
2019 · 1.400 Zit.